Exosomal‐complement system activation in preeclampsia
Journal of Obstetrics and Gynaecology Research · 2025-03 · 51 (3)
DOI: 10.1111/jog.16255 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 11.03.2025. Verfasst von M David und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South …. Hauptthemen laut MEDLINE: Pre-Eclampsia, Exosomes, Complement Activation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aim
Preeclampsia ( PE ) is a severe pregnancy‐related disorder characterized by hypertension and multi‐organ failure, primarily affecting the maternal vasculature and placenta. The aim of this review is to explain the molecular mechanisms behind PE by investigating the relationship between exosome release and complement activation, which could provide insight into potential therapeutic targets.
Methods
This review analyzes existing literature on the role of the complement system and exosomes in the pathophysiology of PE. The focus is on how abnormal complement activation contributes to inflammation and vascular dysfunction, particularly in the placenta, and the role of trophoblast‐derived exosomes carrying pathogenic molecules such as soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and soluble endoglin (sEng).
Results
Findings from recent studies indicate that during PE, abnormal complement activation leads to severe inflammation and vascular dysfunction in the placenta. Additionally, exosomes, particularly those derived from trophoblasts, are present in higher concentrations in maternal circulation during PE and carry molecules that disrupt endothelial function. These factors contribute to the development of hypertension and other maternal complications.
Conclusions
Understanding the interaction between complement activation and exosome release in PE may open avenues for novel therapeutic approaches. Targeting complement regulation and exosome‐mediated signaling could potentially improve maternal and fetal outcomes, offering new strategies for managing this complex condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
- Precision Medicine and Integrated Nano-Diagnostics (P-MIND) Research Group, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
ORCID-Profile: M David, N Maharaj, A Krishnan
Zitieren
APA
David, M., Maharaj, N., & Krishnan, A. (2025). Exosomal‐complement system activation in preeclampsia. Journal of Obstetrics and Gynaecology Research, 51(3). https://doi.org/10.1111/jog.16255
Vancouver
David M, Maharaj N, Krishnan A. Exosomal‐complement system activation in preeclampsia. Journal of Obstetrics and Gynaecology Research. 2025;51(3). doi:10.1111/jog.16255
BibTeX
@article{David2025,
author = {David, M and Maharaj, N and Krishnan, A},
title = {Exosomal‐complement system activation in preeclampsia},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
volume = {51},
number = {3},
doi = {10.1111/jog.16255}
}
EUVIMED